San Diego-based Sapphire Energy is pioneering an entirely new industry – Green Crude – production with the potential to profoundly change America’s energy and petrochemical landscape for the better. Sapphire’s products and processes in this category differ significantly from other forms of biofuel because they are made solely from photosynthetic microorganisms (algae and cyanobacteria), using sunlight and CO2 as their feedstock; are not dependent on food crops or valuable farmland; do not use potable water; do not result in biodiesel or ethanol; enhance and replace petroleum-based products; are compatible with existing infrastructure; and are low carbon, renewable and scalable. Sapphire has an R&D facility in Las Cruces, New Mexico, and is currently building the first Integrated Algal BioRefinery in Columbus, New Mexico.

The Research Institute at Nationwide Children's Hospital is one of America's ten largest free-standing pediatric research centers and works to enhance the health of children by engaging in research.

NMC, Inc. engages in mining and ore processing. It focuses on the exploitation of existing inventories of precious metal. The company was founded on April 3, 1984 and is headquartered in Arrington, TN.

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.

Beijing Institute of Genomics, Chinese Academy of Sciences (doing business as China Academy of Sciences Beijing Jiyinzu Research Laboratory) is a Chinese private company located in Beijing. The firm provides medical research services.

Los Alamos National Security LLC is an American private company located in Los Alamos, NM. The firm provides research, development and testing services.

The Korea Atomic Energy Research Institute (KAERI) in Daejeon, South Korea was established in 1959 as the sole professional research-oriented institute for nuclear power in South Korea, and has rapidly built a reputation for research and development in various fields. In 1995 KAERI designed and constructed the nation's first multipurpose research reactor, HANARO based on the Canadian MAPLE design. KAERI is dedicated to finding a wide range of uses for atomic energy. As examples, KAERI developed the world's first radiopharmaceutical "Milican injection" for treating liver cancer.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

TerraVia Holdings, Inc. (formerly Solazyme) was a publicly held biotechnology company in the United States. TerraVia used proprietary technology to transform a range of low-cost plant-based sugars into high-value oils and whole algae ingredients. TerraVia supplies a variety of sustainable algae-based food ingredients to a number of brands, which have included Hormel Food Corporation, Utz Quality Foods Inc., and Enjoy Life Foods. TerraVia also sold its own culinary algae oil under the Thrive Algae Oil brand.

Ylichron SRL is an Italian private company that provides professional, scientific and technical services.

Shanxi Touyun Biotechnology Co., Ltd., established on 2020-03-09, Business scope includes biological products,R&D, production and sales of microalgae and derivatives(Except where restricted or prohibited by the state);food business:Health product production,Sales;food production;Chemical Products(Hazardous chemicals excluded)research and development,production and sales;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Wuhan Jingyu Microalgae Technology Co., Ltd., established on 2013-11-25, Business scope includes research and development of feed;Environmental product technology development,Sales;Biological carbon sequestration technology development,technology transfer;Sales of primary agricultural products;Wholesale and retail of prepackaged food.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

RENEW BIOPHARMA IS A DRUG DISCOVERY COMPANY USING SYNTHETIC BIOLOGY PLATFORM TO PRODUCE A PIPELINE OF DRUG MOLECULES FOR NEUROINFLAMMATORY CONDITIONS (INCLUDING TRAUMATIC BRAIN INJURY). Renew has developed a novel enzymatic platform by synthetic biology to create a diverse pipeline of proprietary therapeutic molecules (i.e. alkylresorcinol scaffold derivatives; similar to CBGA). Uniquely, Renew’s scaffold molecules pass the blood brain barrier and engage a classic cellular receptor that controls inflammation (i.e. PPAPγ), together making this family of molecules particularly useful for indications of neuro-therapeutics. Renew is specifically focused on developing therapeutics to treat neuroinflammation pathologies, with specific focus on Traumatic Brain Injury (TBI). No drug treatment is currently approved by the FDA for TBI, while millions of patients from all age groups are effected worldwide annually. Renew’s proprietary “enzymatic chemistry” processes are in stark contrast to traditional “medicinal chemistry” processes commonly employed by Big Pharma. While traditional medicinal chemistry often requires noxious reaction components and exhibits low synthesis efficiencies, Renew’s custom engineered “enzymatic reactions” are highly efficient and scalable. These enzymatic reactions are particularly amenable for alkylresorcinol scaffold derivative molecules (that require prenylation-type synthesis). Renew’s platform for creating therapeutic derivatives by engineered enzymes is covered by a robust IP portfolio related to key enzymes (and engineered variants thereof) for production of alkylresorcinol derivatives by prenylation processes.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.